Literature DB >> 12896940

What happened to the valid POEMs? A survey of review articles on the treatment of type 2 diabetes.

Allen F Shaughnessy1, David C Slawson.   

Abstract

OBJECTIVE: To evaluate systematically the review literature on type 2 diabetes to assess transmission of the findings of the United Kingdom prospective diabetes study (UKPDS), an important source of recent valid patient oriented evidence that matters (POEMs).
DESIGN: Inception cohort analysis of the recent medical literature. STUDIES REVIEWED: Thirty five reviews on treatment of type 2 diabetes. MAIN OUTCOME MEASURES: Presentation of three types of information from UKPDS in review articles: recommendations based on patient oriented outcomes of study; recommendations contradicted by patient oriented outcomes of study; and recommendations based on disease oriented outcomes for which no patient oriented evidence exists.
RESULTS: Only six of the reviews included the POEM that tight blood glucose control had no effect on diabetes related or overall mortality. Just seven mentioned that metformin treatment was associated with decreased mortality. Most (30) of the reviews did not report that diabetic patients with hypertension benefit more from good blood pressure control than good blood glucose control. No review pointed out that treatment of overweight patients with type 2 diabetes with insulin or sulphonylurea drugs had no effect on microvascular or macrovascular outcomes. Thirteen reviews recommended drugs as first line treatment for which we do not have patient oriented outcomes data. The average validity assessment score was 1.3 out of a possible score of 15 (95% confidence interval 0.9 to 1.8).
CONCLUSIONS: Review articles on the treatment of type 2 diabetes have not accurately transmitted the valid POEM results of the UKPDS to clinicians. Clinicians relying on review articles written by experts as a source of valid POEMs may be misled.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12896940      PMCID: PMC167157          DOI: 10.1136/bmj.327.7409.266

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  21 in total

1.  Seeing what you want to see in randomised controlled trials: versions and perversions of UKPDS data. United Kingdom prospective diabetes study.

Authors:  J McCormack; T Greenhalgh
Journal:  BMJ       Date:  2000-06-24

2.  The medical review article revisited: has the science improved?

Authors:  F A McAlister; H D Clark; C van Walraven; S E Straus; F M Lawson; D Moher; C D Mulrow
Journal:  Ann Intern Med       Date:  1999-12-21       Impact factor: 25.391

3.  How to write an evidence-based clinical review article.

Authors:  Jay Siwek; Margaret L Gourlay; David C Slawson; Allen F Shaughnessy
Journal:  Am Fam Physician       Date:  2002-01-15       Impact factor: 3.292

Review 4.  The case against aggressive treatment of type 2 diabetes: critique of the UK prospective diabetes study.

Authors:  R M Ewart
Journal:  BMJ       Date:  2001-10-13

5.  Glycaemia and vascular effects of type 2 diabetes. UKPDS is not a cohort study and analysis is misleading.

Authors:  J K Cruickshank
Journal:  BMJ       Date:  2001-05-19

6.  Are thiazolidinediones first-line agents?

Authors:  David L Weldy
Journal:  J Fam Pract       Date:  2002-11       Impact factor: 0.493

Review 7.  Oral agents in the management of type 2 diabetes mellitus.

Authors:  B Luna; M N Feinglos
Journal:  Am Fam Physician       Date:  2001-05-01       Impact factor: 3.292

8.  Clinical review articles.

Authors:  R B Haynes
Journal:  BMJ       Date:  1992-02-08

9.  The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus.

Authors:  E S Huang; J B Meigs; D E Singer
Journal:  Am J Med       Date:  2001-12-01       Impact factor: 4.965

Review 10.  Optimisation of the management of patients with coronary heart disease and type 2 diabetes mellitus.

Authors:  S H Wilson; F P Kennedy; K N Garratt
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

View more
  9 in total

1.  Research was evidence based.

Authors:  Allen F Shaughnessy; David C Slawson
Journal:  BMJ       Date:  2003-10-04

2.  Is tight glycemic control in type 2 diabetes really worthwhile? No.

Authors:  Galt Wilson; Thomas Perry
Journal:  Can Fam Physician       Date:  2009-06       Impact factor: 3.275

3.  Coronary heart disease prevention in clinical practice: are patients with diabetes special? Evidence from two studies of older men and women.

Authors:  J R Emberson; P H Whincup; D A Lawlor; D Montaner; S Ebrahim
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

4.  Should we be teaching information management instead of evidence-based medicine?

Authors:  Shepard R Hurwitz; David C Slawson
Journal:  Clin Orthop Relat Res       Date:  2010-10       Impact factor: 4.176

5.  Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial.

Authors:  D Merenstein; M Murphy; A Fokar; R K Hernandez; H Park; H Nsouli; M E Sanders; B A Davis; V Niborski; F Tondu; N M Shara
Journal:  Eur J Clin Nutr       Date:  2010-05-19       Impact factor: 4.016

Review 6.  Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials.

Authors:  Rémy Boussageon; Theodora Bejan-Angoulvant; Mitra Saadatian-Elahi; Sandrine Lafont; Claire Bergeonneau; Behrouz Kassaï; Sylvie Erpeldinger; James M Wright; François Gueyffier; Catherine Cornu
Journal:  BMJ       Date:  2011-07-26

7.  Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials.

Authors:  Rémy Boussageon; Irène Supper; Theodora Bejan-Angoulvant; Nadir Kellou; Michel Cucherat; Jean-Pierre Boissel; Behrouz Kassai; Alain Moreau; François Gueyffier; Catherine Cornu
Journal:  PLoS Med       Date:  2012-04-10       Impact factor: 11.069

Review 8.  Hypertension and diabetes: should we treat early surrogates? What are the cons?

Authors:  Peter M Nilsson
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

9.  So what? A framework for assessing the potential impact of intervention research.

Authors:  Jonathan E Fielding; Steven M Teutsch
Journal:  Prev Chronic Dis       Date:  2013       Impact factor: 2.830

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.